The effect of plant stanol- and sterol-enriched foods on lipid metabolism, serum lipids and coronary heart disease

Annals of Clinical Biochemistry

Volumn 42, Issue 4, 2005, Pages 254-263

  Gylling, Helena ^a   Miettinen, Tatu A ^b,c  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c BIOMEDICUM HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; BETA CAROTENE; CAMPESTANOL; CAMPESTEROL; CHOLESTANOL; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; PHYTOSTEROL; SITOSTANOL; SITOSTEROL; STANOL ESTER;

ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL METABOLISM; FUNCTIONAL FOOD; HUMAN; HYPERCHOLESTEROLEMIA; INTESTINE ABSORPTION; ISCHEMIC HEART DISEASE; LIPID METABOLISM; LONG TERM CARE; MALABSORPTION; PRIORITY JOURNAL; REVIEW;

CORONARY ARTERIOSCLEROSIS; DIET; FOOD, FORTIFIED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIPID METABOLISM; LIPIDS; PHYTOSTEROLS;

EID: 21844471768     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563054255605     Document Type: Review

References (69)

1. Björkhem I, Boberg KM, Leitersdorf E. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Scriver CS, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2001; 2961-88
2. Teshima S-I. Sterols of crustaceans, molluscs and fish. In: Patterson GW, Nes WD, eds. Physiology and Biochemistry of Sterols. Champaign, IL: American Oil Chemists' Society, 1991; 229-56
3. Berge KE. Sitosterolemia: a gateway to new knowledge about cholesterol metabolism. Ann Med 2003; 35: 502-11
4. Liebson PR. Clinical trial update: PROVE IT and REVERSAL. Prev Cardiol 2004; 7: 138-42
5. Buchwald H, Varco RL, Boen JR, et al. Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year post trial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias. Arch Intern Med 1998; 158: 1253-61
6. Moreau RA, Whitaker BD, Hicks KB. Phytosterols, phytostanols, and their conjugates in foods: structural diversity, quantitative analysis, and health-promoting uses. Progr Lipid Res 2002; 41: 457-500
7. Normen L, Frohlich J, Trautwein E. Role of plant sterols in cholesterol lowering. In: Dutta PC, ed. Phytosterols as Functional Food Components and Nutraceuticals. New York, Basel: Marcel-Dekker, Inc, 2004; 243-315
8. Ratnayake WMN, Vavasour EJ. Potential health risks associated with large intakes of plant sterols. In: Dutta PC, ed. Phytosterols as Functional Food Components and Nutraceuticals. New York, Basel: Marcel-Dekker, Inc, 2004; 365-95
9. Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R, for the Stresa Workshop Participants. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 2003; 78: 965-78
10. Piironen V, Lindsay DG, Miettinen TA, Toivo J, Lampi A-M. Plant sterols: biosynthesis, biological function and their importance to human nutrition. J Sci Food Agric 2000; 80: 939-66
11. Pollak OJ, Kritchevsky D. Sitosterol. In: Clarkson TB, Kritchevsky D, Pollak OJ, eds. Monographs on Atherosclerosis. Vol 10 Basel: Karger, 1981; 1-219
12. Vanhanen H, Miettinen TA. Effects of sitostanol esters, dissolved in dietary oil, on serum cholesterol, plant sterols and cholesterol precursors. Circulation 1991; 84: II-601
13. Miettinen TA, Puska P, Gylling H, Vanhanen HT, Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 1995; 333: 1308-12
14. Mattson FH, Volpenheim RA, Erickson BA. Effect of plant sterol esters on the absorption of dietary cholesterol. J Nutr 1977; 107: 1139-46
15. Weststrate JA, Meijer GW. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 1998; 52: 334-43
16. Denke MA. Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia. Am J Clin Nutr 1995; 61: 392-6
17. Nestel P, Cehun M, Pomeroy S, Abbey M, Weldon G. Cholesterol-lowering effects of plant sterol esters and non-esterified stanols in margarine, butter and low-fat foods. Eur J Clin Nutr 2001; 55: 1084-90
18. Mensink RP, Ebbing S, Lindhout M, Plat J, van Heugten MM. Effects of plant stanol esters supplied in low-fat yoghurt on serum lipids and lipoproteins, non-cholesterol sterols and fat soluble antioxidant concentrations. Atherosclerosis 2002; 160: 205-13
19. Jones PJ, Vanstone CA, Raeini-Sarjaz M, St-Onge MP. Phytosterols in low- and nonfat beverages as part of a controlled diet fail to lower plasma lipid levels. J Lipid Res 2003; 44: 1713-1719
20. Vanhanen HT, Blomqvist S, Ehnholm C, et al. Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment. J Lipid Res 1993; 34: 1535-44
21. Ikeda I, Tanabe Y, Sugano M. Effects of sitosterol and sitostanol on micellar solubility of cholesterol. J Nutr Sci Vitaminol 1989; 35: 361-9
22. Nissinen M, Gylling H, Vuoristo M, Miettinen TA. Micellar distribution of cholesterol and phytosterols after duodenal plant stanol ester infusion. Am J Physiol Gastrointest Liver Physiol 2002; 282: G1009-15
23. Miettinen TA, Vuoristo M, Nissinen M, Järvinen HJ, Gylling H. Serum, biliary, and fecal cholesterol and plant sterols in colectomized patients before and during consumption of stanol ester margarine. Am J Clin Nutr 2000; 71: 1095-102
24. Heinemann T, Axtmann G, von Bergmann K. Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur J Clin Invest 1993; 23: 827-31
25. 5-phytosterols and phytostanols in humans. Am J Physiol Endocrinol Metab 2002; 282: E911-6
26. Miettinen TA, Gylling H, Vanhanen H, Ollus A. Cholesterol absorption elimination and synthesis related to low density lipoprotein kinetics during varying fat intake in men with different apoprotein E phenotypes. Arterioscler Thromb 1999; 12: 1044-1052
27. Gylling H, Miettinen TA. Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoprotein E phenotypes. J Lipid Res 1992; 33: 1361-71
28. Ketomäki AM, Gylling H, Antikainen M, Siimes MA, Miettinen TA. Red cell and plasma plant sterols are related during consumption of plant stanol and sterol ester spreads in children with hypercholesterolemia. J Pediatr 2003; 142: 524-31
29. Tilvis RS, Miettinen TA. Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr 1986; 43: 92-7
30. Miettinen TA, Tilvis RS, Kesäniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990; 131: 20-31
31. Bhattacharyya AK, Connor WE. Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest 1974; 53: 1033-43
32. Gagné C, Bays HE, Weiss SR, et al. Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia. Am J Cardiol 2002; 90: 1084-91
33. Salen G, von Bergmann K, Lütjohann D, et al. Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation 2004; 109: 966-71
34. Salen G, Xu G, Tint GS, Batta AK, Shefer S. Hyperabsorption and retention of campestanol in a sitosterolemic homozygote: comparison with her mother and three control subjects. J Lipid Res 2000; 41: 1883-9
35. Altmann SW, Davis Jr HR, Zhu L, et al. Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science 2004; 303: 1201-4
36. Plat J, Mensink RP. Increased intestinal ABCA1 expression contributes to the decrease in cholesterol absorption after plant stanol consumption. FASEB J 2002; 16: 1248-53
37. Miettinen TA. Gas-liquid chromatographic determination of fecal neutral sterols using capillary column. Clin Chim Acta 1982; 124: 245-8
38. Miettinen TA, Gylling H. Non-nutritive bioactive constituents of plants: phytosterols. Int J Vitam Nutr Res 2003; 73: 127-34
39. Jones PJ, Raeini-Sarjaz M, Ntanios FY, Vanstone CA, Feng JY, Parsons WE. Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res 2000; 41: 697-705
40. Grundy SM, Ahrens Jr EH, Davignon J. The interaction of cholesterol absorption and cholesterol synthesis in man. J Lipid Res 1969; 10: 304-15
41. O'Neill FH, Brynes A, Mandeno R, et al. Comparison of the effects of dietary plant sterol and stanol esters on lipid metabolism. Nutr Metab Cardiovasc Dis 2004; 14: 133-42
42. Weststrate JA, Ayesh R, Bauer-Plank C, Drewitt PN. Safety evaluation of phytosterol esters. Part 4. Faecal concentrations of bile acids and neutral sterols in healthy normolipidaemic volunteers consuming a controlled diet either with or without a phytosterol ester-enriched margarine. Food Chem Toxicol 1999; 37: 1063-71
43. Ketomäki A, Gylling H, Miettinen TA. Non-cholesterol sterols in serum, lipoproteins, and red cells in statin-treated FH subjects off and on plant stanol and sterol ester spreads. Clin Chim Acta 2005; 353: 75-86
44. Miettinen TA, Strandberg TE, Gylling H, for the Finnish investigators of the Scandinavian Simvastatin Survival Study Group. Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients, relation to basal serum cholestanol. Arterioscler Thromb Vasc Biol 2000; 20: 1340-6
45. Neil HAW, Meijer GW, Roe LS. Randomised controlled trial of use by hypercholesterolaemic patients of a vegetable oil sterol-enriched fat spread. Atherosclerosis 2001; 156: 329-37
46. Ketomäki A, Gylling H, Miettinen TA. Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subjects. J Lab Clin Med 2004; 143: 255-62
47. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003; 326: 1423-9
48. Law M. Plant sterol and stanol margarines and health. Br Med J 2000; 320: 861-4
49. Miettinen TA, Gylling H. Plant stanol and sterol esters in prevention of cardiovascular disease. Ann Med 2004; 36: 126-134
50. Mussner MJ, Parhofer KG, von Bergmann K, Schwandt P, Broedl U, Otto C. Effects of phytosterol ester-enriched margarine on plasma lipoproteins in mild to moderate hypercholesterolemia are related to basal cholesterol and fat intake. Metabolism 2002; 51: 189-94
51. Davidson MH, Maki KC, Umporowicz DM, et al. Safety and tolerability of esterified phytosterols administered in reduced-fat spread and salad dressing to healthy adult men and women. J Am Coll Nutr 2001; 4: 307-19
52. Lee YM, Haastert B, Scherbaum W, Hauner H. A phytosterol-enriched spread improves the lipid profile of subjects with type 2 diabetes mellitus. A randomized controlled trial under free-living conditions. Eur J Nutr 2003; 42: 111-7
53. Gylling H, Miettinen TA. Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia 1994; 37: 773-80
54. Gylling H, Miettinen TA. The effects of inhibiting cholesterol synthesis and absorption on cholesterol and lipoprotein metabolism in hypercholesterolemic non-insulin dependent diabetic men. J Lipid Res 1996; 37: 1776-85
55. Plat J, Mensink RP. Effects of plant stanol esters on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase mRNA expression in mononuclear blood cells of healthy men and women. FASEB J 2002; 16: 258-60
56. Gylling H, Hallikainen M, Pihlajamäki J, et al. Polymorphisms in the ABCG5 and ABCG8 genes associate with cholesterol absorption and insulin sensitivity. J Lipid Res 2004; 45: 1660-5
57. Miettinen TA, Gylling H. Ineffective decrease of serum cholesterol by simvastatin in a subgroup of hypercholesterolemic coronary patients. Atherosclerosis 2002; 164: 147-52
58. Kesäniemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 1987; 80: 578-81
59. Thies F, Garry JMC, Yaqoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003; 361: 477-85
60. Hendriks HFJ, Brink EJ, Meijer GW, Princen HMG, Ntanios FY. Safety of long-term consumption of plant sterol esters-enriched spread. Eur J Clin Nutr 2003; 57: 681-92
61. Gylling H, Miettinen TA. LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects. Nutr Metab Cardiovasc Dis 2002; 12: 19-23
62. Miettinen TA, Gylling H, Lindbohm N, Miettinen TE, Rajaratnam RA, Relas H, for the Finnish Treat-to-Target Study investigators. Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins. J Lab Clin Med 2003; 141: 131-7
63. Miettinen TA, Gylling H. Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment. Eur J Clin Invest 2003; 33: 976-82
64. Miettinen TA, Gylling H, Strandberg T, Sarna S, for the Finnish 4S Investigators. Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. BMJ 1998; 316: 1127-30
65. Glueck CJ, Speirs J, Tracy T, Streicher P, Illig E, Vandegrift J. Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives. Metabolism 1991; 40: 842-8
66. Sutherland WHF, Williams MJA, Nye ER, Restieaux NJ, de Jong SA, Walker HL. Association of plasma noncholesterol sterol levels with severity of coronary artery disease. Nutr Metab Cardiovasc Dis 1998; 8: 386-91
67. Rajaratnam RA, Gylling H, Miettinen TA. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women. J Am Coll Cardiol 2000; 35: 1185-91
68. Sudhop T, Gottwald BM, von Bergmann K. Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism 2002; 51: 1519-21
69. Assmann G, Cullen P, Erbey J, Ramey DR, Kannenberg F, Schulte H. Elevation in plasma sitosterol concentration is associated with an increased risk for coronary events in the PROCAM study. Circulation 2003; 108, IV-730